229 related articles for article (PubMed ID: 31155574)
1. Exploring Novel Cocrystalline Forms of Oxyresveratrol to Enhance Aqueous Solubility and Permeability across a Cell Monolayer.
Suzuki Y; Muangnoi C; Thaweesest W; Teerawonganan P; Ratnatilaka Na Bhuket P; Titapiwatanakun V; Yoshimura-Fujii M; Sritularak B; Likhitwitayawuid K; Rojsitthisak P; Fukami T
Biol Pharm Bull; 2019; 42(6):1004-1012. PubMed ID: 31155574
[TBL] [Abstract][Full Text] [Related]
2. Four Novel Pharmaceutical Cocrystals of Oxyresveratrol, Including a 2 : 3 Cocrystal with Betaine.
Sakamoto N; Tsuno N; Koyama R; Gato K; Titapiwatanakun V; Takatori K; Fukami T
Chem Pharm Bull (Tokyo); 2021; 69(10):995-1004. PubMed ID: 34602581
[TBL] [Abstract][Full Text] [Related]
3. Exploring potential coformers for oxyresveratrol using principal component analysis.
Ouiyangkul P; Tantishaiyakul V; Hirun N
Int J Pharm; 2020 Sep; 587():119630. PubMed ID: 32652183
[TBL] [Abstract][Full Text] [Related]
4. Effect of Coformer Selection on In Vitro and In Vivo Performance of Adefovir Dipivoxil Cocrystals.
Li L; Pang Z; Ma K; Gao Y; Zheng D; Wei Y; Zhang J; Qian S
Pharm Res; 2021 Oct; 38(10):1777-1791. PubMed ID: 34729701
[TBL] [Abstract][Full Text] [Related]
5. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
Basavoju S; Boström D; Velaga SP
Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
[TBL] [Abstract][Full Text] [Related]
6. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
[TBL] [Abstract][Full Text] [Related]
7. Novel Aceclofenac Cocrystals with l-Cystine: Virtual Coformer Screening, Mechanochemical Synthesis, and Physicochemical Investigations.
Kumar S; Gupta A; Prasad R; Singh S
Curr Drug Deliv; 2021; 18(1):88-100. PubMed ID: 32807053
[TBL] [Abstract][Full Text] [Related]
8. Cocrystal Construction Between Rosuvastatin Calcium and L-asparagine with Enhanced Solubility and Dissolution Rate.
Vemuri VD; Lankalapalli S
Turk J Pharm Sci; 2021 Dec; 18(6):790-798. PubMed ID: 34979738
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical Cocrystal: A Novel Approach to Tailor the Biopharmaceutical Properties of a Poorly Water Soluble Drug.
Srivastava D; Fatima Z; Kaur CD; Tulsankar SL; Nashik SS; Rizvi DA
Recent Pat Drug Deliv Formul; 2019; 13(1):62-69. PubMed ID: 30848223
[TBL] [Abstract][Full Text] [Related]
10. Development and Characterization of Dapsone Cocrystal Prepared by Scalable Production Methods.
do Amaral LH; do Carmo FA; Amaro MI; de Sousa VP; da Silva LCRP; de Almeida GS; Rodrigues CR; Healy AM; Cabral LM
AAPS PharmSciTech; 2018 Aug; 19(6):2687-2699. PubMed ID: 29968042
[TBL] [Abstract][Full Text] [Related]
11. Improved pharmaceutical properties of ritonavir through co-crystallization approach with liquid-assisted grinding method.
Chaudhari KR; Savjani JK; Savjani KT; Shah H
Drug Dev Ind Pharm; 2021 Oct; 47(10):1633-1642. PubMed ID: 35156497
[TBL] [Abstract][Full Text] [Related]
12. Dissolution improvement and the mechanism of the improvement from cocrystallization of poorly water-soluble compounds.
Shiraki K; Takata N; Takano R; Hayashi Y; Terada K
Pharm Res; 2008 Nov; 25(11):2581-92. PubMed ID: 18651208
[TBL] [Abstract][Full Text] [Related]
13. Glibenclamide-malonic acid cocrystal with an enhanced solubility and bioavailability.
Srivastava D; Fatima Z; Kaur CD; Mishra A; Nashik SS; Rizvi DA; Prasad R
Drug Dev Ind Pharm; 2022 Aug; 48(8):417-424. PubMed ID: 36073946
[TBL] [Abstract][Full Text] [Related]
14. Novel cocrystals of itraconazole: Insights from phase diagrams, formation thermodynamics and solubility.
Vasilev NA; Surov AO; Voronin AP; Drozd KV; Perlovich GL
Int J Pharm; 2021 Apr; 599():120441. PubMed ID: 33675927
[TBL] [Abstract][Full Text] [Related]
15. Novel furosemide cocrystals and selection of high solubility drug forms.
Goud NR; Gangavaram S; Suresh K; Pal S; Manjunatha SG; Nambiar S; Nangia A
J Pharm Sci; 2012 Feb; 101(2):664-80. PubMed ID: 22081478
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of physicochemical, pharmaceutical, and pharmacokinetic properties of lornoxicam by cocrystallization with a novel coformer.
Fatima K; Bukhari NI; Latif S; Afzal H; Hussain A; Shamim R; Abbas N
Drug Dev Ind Pharm; 2021 Mar; 47(3):498-508. PubMed ID: 33646919
[TBL] [Abstract][Full Text] [Related]
17. Two novel cocrystals of lamotrigine with isomeric bipyridines and in situ monitoring of the cocrystallization.
Du S; Wang Y; Wu S; Yu B; Shi P; Bian L; Zhang D; Hou J; Wang J; Gong J
Eur J Pharm Sci; 2017 Dec; 110():19-25. PubMed ID: 28587788
[TBL] [Abstract][Full Text] [Related]
18. Cocrystal formation, crystal structure, solubility and permeability studies for novel 1,2,4-thiadiazole derivative as a potent neuroprotector.
Surov AO; Volkova TV; Churakov AV; Proshin AN; Terekhova IV; Perlovich GL
Eur J Pharm Sci; 2017 Nov; 109():31-39. PubMed ID: 28756204
[TBL] [Abstract][Full Text] [Related]
19. Cocrystal formation of loratadine-succinic acid and its improved solubility.
Setyawan D; Adyaksa FR; Sari HL; Paramita DP; Sari R
J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):623-630. PubMed ID: 34214360
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Characterization of a (-)-Epicatechin and Barbituric Acid Cocrystal: Single-Crystal X-ray Diffraction and Vibrational Spectroscopic Studies.
Budziak-Wieczorek I; Maciołek U
ACS Omega; 2021 Mar; 6(12):8199-8209. PubMed ID: 33817479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
